<qa>  What will be assessed as changes in symptoms and pain?Clinical effects will be assessed as changes in symptoms and pain VISA-A and VAS score, tendon ultrasound thickness and color Doppler. All outcome measures will be recorded at baseline and again at 6 weeks, 12 weeks and 24 weeks follow-up. 